Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Tirzepatide Following Administration to Subjects With Impaired Renal Function

NCT03482024 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT03482024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03482024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Tirzepatide Following Administration to Subjects With Impaired Renal Function
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
March 30, 2018
Completion date
August 19, 2019
Enrollment
45 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, renal insufficiency